1田勇泉,主编.耳鼻咽喉-头颈外科学[M].北京:人民卫生出版社,2004.355~358.

2 Parisier SC,Agreti CJ,Schwartz GK,et al.Alteration in chol-esteatoma fibroblasts:induction of neoplastic-like phenotype[J].Am J Otol,1993,14:126.

3 Bujia J,Schilling V,Holly A,et al.Hyperproliferation-asso-ciated keratin expression in human middle ear choleseatoma[J].Acta Otolaryngol,1993,113:364.

4 Ergun S,Zheng X,Carsoo B.Antigen expression of epithelialmakers,collagenⅣand Ki67 in middle ear cholesteatoma[J].Acta Otolaryngol,1994,114:295.

5 Kuczkowski J,Pawelczyk T,Bakowska A,et al.Expressionpatterns of Ki67 and telomerase activity in middle ear chol-esteatoma[J].Otol Neurotol,2007,28:204.

6 Bujia J,Holly A,Schilling V,et al.Aberrant exprssion of epi-dermal growth factor receptor in aural cholesteatoma[J].La-ryngoscope,1993,103:326.

7余其林,金康业.中耳胆脂瘤上皮细胞增生与凋亡状态的研究[J].临床耳鼻咽喉科杂志,2001,15:450.

8崔永华,潘宏光,高起学.中耳胆脂瘤上皮细胞DNA的特征[J].临床耳鼻咽喉科杂志,2001,15:62.

9龚非力,主编.基础免疫学[J].武汉:湖北科学技术出版社,1998.328~329.

10 Albino AP,Reed JA,Bogdany JK,et al.expression of p53protein in human middle ear cholesteatomas:pathpgenetic im-pications[J].Am J Otol,1998,19:30.

11 Olszewska E,Chodynicki S,Chyczewski L.Apoptosis in thepathogenesis of cholesteatoma in adults[J].Eur Arch Oto-rhinolaryngol,2006,263:409.

12 Cory S,Huang DC,Adams JM.the Bcl-2 family:roles in cellsurvival and oncogenesis[J].Oncogene,2003,22:6 590.

13 Kojima H,Miyazaki H,Tanaka Y,et al.Role of Bcl-xl pro-tein in differentiation and apoptosis of human middle ear chol-esteatoma epithelium[J].Arch Otolaryngol Head NeckSurg,1999,125:738.

14 Holly A,Sittinger M,Bujia J.Immunohistochemical detectionof c-myc proto-oncogene products in middle ear chol-esteatoma[J].Laryngorhinootologie,1995,74:346.

15 Shinoda H,Huang CC.Expressions of c-jun and p53 pro-teins in human middle ear cholesteatoma:relationship to kera-tinocyte proliferation,differentiation,and programmed celldeath[J].Laryngoscope,1995,105:1 232.

16 Huang CC,Chen CT,Huang TS,et al.Mediation of signaltransductive in keratinocytes of human middle ear chol-esteatoma by ras protein[J].Eur Arch Otorhinolaryngol,1996,253:385.

17 Ladanyi M,Cha C,Lewis R,et al.MDM2 gene amplificationin metastatic osteosarcoma[J].Cancer Res,1993,53:16.

18 Lahav G,Rosenfeld N,Sigal A,et al.Dynamics of the p53-MDM2 feedback loop in individual cells[J].Nat Genet,2004,36:147.

19 Amar MS,Wishahi HF,Zakhary MM.Clinical and biochemi-cal studies of bone destruction in cholesteatomav[J].J Lar-yngol Otol,1996,110:534.

20李正贤,李学佩,刘庚勋,等.肿瘤坏死因子-α在中耳胆脂瘤中的表达及其意义[J].耳鼻咽喉-头颈外科,2000,7:287.

21 Chung JW,Yoon TH.Different production of interleukin-1-alpha,interleukin-1-beta and interleukin-8 from chol-esteatomatous and normal epithelium[J].Acta Otolaryngol,1998,118:386.

22 Bujia J,Kim C,Boyle D,et al.Quantitative analysis of inter-leukin 1-alpha gene expression in middle ear choleseatoma[J].Laryngoscope,1996,106(2 Pt 1):217.

23 Akimoto R,Pawankar R,Yagi T,et al.Acquired and congeni-tal cholesteatoma:determination of tumor necrosis factor-al-pha,intercellular adhesion molecule-1,interleukin-1-al-pha and lymphocyte functional antigen-1 in the inflammato-ry process[J].ORL J Otorhinolaryngol Relat Sepc,2000,62:257.

24王辉兵,徐志文,唐安洲。胆脂瘤型中耳炎骨质破坏机制的组织酶学研究[J].耳鼻咽喉-头颈外科,2002,9:62.

25 Bernal SM,Ebmeyer J,Anonopoulous AK,et al.Alterationsof the basal membrane in middle ear cholesteatoma[J].ActaOtorrinolaringol Esp,2001,52:330.

26 Matthias P,Schonermark MD,Peter R,et al.Expression pat-tern of the plasminogen activator-plasmin system in humancholesteatoma[J].Ann Otol Rhinol Laryngol,1999,108:245.

27 Ahn JM,Huang CC,Abramson M.Interleukin 1 causing bonedestruction in middle ear cholesteatoma[J].OtolaryngolHeak Neck Surg,1999,103:527.